Search Within

Semanti Mukherjee

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (11)
Groups
  1. Alumni (GSK) (28)
  2. Clinical Genetics Service (28)
  3. Department of Medicine (28)
  4. Department of Pathology and Laboratory Medicine (28)
  5. GSK Faculty (28)
  6. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (28)

More Groups

People
  1. Kenneth Offit (26)
  2. Diana Mandelker (23)
  3. Yelena Kemel (23)
  4. Mark Robson (21)
  5. Michael Berger (21)
  6. Zsofia Stadler (21)

More People

Years
  1. 2025 (1)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (3)
  3. JCO Precision Oncology (3)
  4. Cancer Epidemiology Biomarkers and Prevention (2)
  5. Clinical Cancer Research (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (8)
  3. Nature Publishing Group (3)
  4. American Medical Association (2)
  5. American Association for the Advancement of Science (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population
    Journal Article

    Salo-Mullen, E. E.; Maio, A.; Mukherjee, S.; Bandlamudi, C.; Shia, J. R.; Kemel, Y.; Cadoo, K. A.; Liu, Y.; Carlo, M.; Ranganathan, M.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in tumors with genomic features of homologous recombination repair defects
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D. N.; Powell, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Protein-altering germline mutations implicate novel genes related to lung cancer development
    Journal Article

    Ji, X.; Mukherjee, S.; Landi, M. T.; Bosse, Y.; Joubert, P.; Zhu, D.; Gorlov, I.; Xiao, X.; Han, Y.; Gorlova, O.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination deficient tumors
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Cadoo, K.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save